APO Research
Talk to an analyst

APO RESEARCH · REPORT

Skin Patch

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Skin Patch Market Outlook and Growth Opportunities 2026

21 December 2025198 pages

Choose your research edition.

Industry ResearchSkin Patch Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Skin Patch Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Skin Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Skin Patch Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Skin Patch Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Skin Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Skin Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Skin Patch market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Skin Patch market include GSK, Teva Pharmaceutical Industries, Sanofi, Johnson & Johnson, Novartis, Mylan, Lingrui, Bayer and Teikoku Seiyaku, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Skin Patch market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Skin Patch and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Skin Patch sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Skin Patch market size, projected growth trends, production technologies, key applications, and end-use industries.

Skin Patch Segment by Company

GSK

Teva Pharmaceutical Industries

Sanofi

Johnson & Johnson

Novartis

Mylan

Lingrui

Bayer

Teikoku Seiyaku

Purdue Pharma

Mundipharma International

Luye Pharma Group

Hisamitsu Pharmaceutical

Skin Patch Segment by Type

Buprenorphine

Fentanyl

Clonidine

Nicotine

Skin Patch Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Skin Patch Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Skin Patch status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Skin Patch market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Skin Patch significant trends, drivers, influence factors in global and regions.

6. To analyze Skin Patch competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Skin Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Skin Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Skin Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Skin Patch market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Skin Patch industry.

Chapter 3: Detailed analysis of Skin Patch manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Skin Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Skin Patch in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Skin Patch Industry Trends Table 2. Skin Patch Industry Drivers Table 3. Skin Patch Industry Opportunities and Challenges Table 4. Skin Patch Industry Restraints Table 5. Global Skin Patch Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Skin Patch Revenue Share by Company (2021-2026) Table 7. Global Skin Patch Sales Volume by Company (k pcs) & (2021-2026) Table 8. Global Skin Patch Sales Volume Share by Company (2021-2026) Table 9. Global Skin Patch Average Price (US$/pcs) of Company (2021-2026) Table 10. Global Skin Patch Company Ranking, (2024-2026) & (USD Million) Table 11. Global Skin Patch Key Company Manufacturing Base & Headquarters Table 12. Global Skin Patch Company, Product Type & Application Table 13. Global Skin Patch Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Skin Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Buprenorphine Table 18. Significant Companies of Fentanyl Table 19. Significant Companies of Clonidine Table 20. Significant Companies of Nicotine Table 21. Global Skin Patch Sales Volume by Type 2021 VS 2025 VS 2032 (k pcs) Table 22. Global Skin Patch Sales Volume by Type (2021-2026) & (k pcs) Table 23. Global Skin Patch Sales Volume by Type (2027-2032) & (k pcs) Table 24. Global Skin Patch Sales Volume Share by Type (2021-2026) Table 25. Global Skin Patch Sales Volume Share by Type (2027-2032) Table 26. Global Skin Patch Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Skin Patch Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Skin Patch Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Skin Patch Sales Value Share by Type (2021-2026) Table 30. Global Skin Patch Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Pharmacies Table 32. Significant Companies of Online Pharmacies Table 33. Significant Companies of Retail Pharmacies Table 34. Global Skin Patch Sales Volume by Application 2021 VS 2025 VS 2032 (k pcs) Table 35. Global Skin Patch Sales Volume by Application (2021-2026) & (k pcs) Table 36. Global Skin Patch Sales Volume by Application (2027-2032) & (k pcs) Table 37. Global Skin Patch Sales Volume Share by Application (2021-2026) Table 38. Global Skin Patch Sales Volume Share by Application (2027-2032) Table 39. Global Skin Patch Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Skin Patch Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Skin Patch Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Skin Patch Sales Value Share by Application (2021-2026) Table 43. Global Skin Patch Sales Value Share by Application (2027-2032) Table 44. Global Skin Patch Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Table 45. Global Skin Patch Sales by Region (2021-2026) & (k pcs) Table 46. Global Skin Patch Sales Market Share by Region (2021-2026) Table 47. Global Skin Patch Sales by Region (2027-2032) & (k pcs) Table 48. Global Skin Patch Sales Market Share by Region (2027-2032) Table 49. Global Skin Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Skin Patch Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Skin Patch Sales Value Share by Region (2021-2026) Table 52. Global Skin Patch Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Skin Patch Sales Value Share by Region (2027-2032) Table 54. Global Skin Patch Market Average Price (US$/pcs) by Region (2021-2026) Table 55. Global Skin Patch Market Average Price (US$/pcs) by Region (2027-2032) Table 56. Global Skin Patch Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Table 57. Global Skin Patch Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Skin Patch Sales by Country (2021-2026) & (k pcs) Table 59. Global Skin Patch Sales Market Share by Country (2021-2026) Table 60. Global Skin Patch Sales by Country (2027-2032) & (k pcs) Table 61. Global Skin Patch Sales Market Share by Country (2027-2032) Table 62. Global Skin Patch Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Skin Patch Sales Value Market Share by Country (2021-2026) Table 64. Global Skin Patch Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Skin Patch Sales Value Market Share by Country (2027-2032) Table 66. GSK Company Information Table 67. GSK Business Overview Table 68. GSK Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 69. GSK Skin Patch Product Portfolio Table 70. GSK Recent Development Table 71. Teva Pharmaceutical Industries Company Information Table 72. Teva Pharmaceutical Industries Business Overview Table 73. Teva Pharmaceutical Industries Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 74. Teva Pharmaceutical Industries Skin Patch Product Portfolio Table 75. Teva Pharmaceutical Industries Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 79. Sanofi Skin Patch Product Portfolio Table 80. Sanofi Recent Development Table 81. Johnson & Johnson Company Information Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 84. Johnson & Johnson Skin Patch Product Portfolio Table 85. Johnson & Johnson Recent Development Table 86. Novartis Company Information Table 87. Novartis Business Overview Table 88. Novartis Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 89. Novartis Skin Patch Product Portfolio Table 90. Novartis Recent Development Table 91. Mylan Company Information Table 92. Mylan Business Overview Table 93. Mylan Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 94. Mylan Skin Patch Product Portfolio Table 95. Mylan Recent Development Table 96. Lingrui Company Information Table 97. Lingrui Business Overview Table 98. Lingrui Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 99. Lingrui Skin Patch Product Portfolio Table 100. Lingrui Recent Development Table 101. Bayer Company Information Table 102. Bayer Business Overview Table 103. Bayer Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 104. Bayer Skin Patch Product Portfolio Table 105. Bayer Recent Development Table 106. Teikoku Seiyaku Company Information Table 107. Teikoku Seiyaku Business Overview Table 108. Teikoku Seiyaku Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 109. Teikoku Seiyaku Skin Patch Product Portfolio Table 110. Teikoku Seiyaku Recent Development Table 111. Purdue Pharma Company Information Table 112. Purdue Pharma Business Overview Table 113. Purdue Pharma Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 114. Purdue Pharma Skin Patch Product Portfolio Table 115. Purdue Pharma Recent Development Table 116. Mundipharma International Company Information Table 117. Mundipharma International Business Overview Table 118. Mundipharma International Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 119. Mundipharma International Skin Patch Product Portfolio Table 120. Mundipharma International Recent Development Table 121. Luye Pharma Group Company Information Table 122. Luye Pharma Group Business Overview Table 123. Luye Pharma Group Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 124. Luye Pharma Group Skin Patch Product Portfolio Table 125. Luye Pharma Group Recent Development Table 126. Hisamitsu Pharmaceutical Company Information Table 127. Hisamitsu Pharmaceutical Business Overview Table 128. Hisamitsu Pharmaceutical Skin Patch Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 129. Hisamitsu Pharmaceutical Skin Patch Product Portfolio Table 130. Hisamitsu Pharmaceutical Recent Development Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Skin Patch Distributors List Table 134. Skin Patch Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Skin Patch Product Image Figure 2. Global Skin Patch Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 4. Global Skin Patch Sales (2021-2032) & (k pcs) Figure 5. Global Skin Patch Sales Average Price (US$/pcs) & (2021-2032) Figure 6. Global Skin Patch Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Buprenorphine Image Figure 10. Fentanyl Image Figure 11. Clonidine Image Figure 12. Nicotine Image Figure 13. Global Skin Patch Sales Volume by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 14. Global Skin Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Skin Patch Sales Volume Share by Type (2021-2032) Figure 16. Global Skin Patch Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Skin Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Skin Patch Sales Value Share by Type (2021-2032) Figure 19. Hospital Pharmacies Image Figure 20. Online Pharmacies Image Figure 21. Retail Pharmacies Image Figure 22. Global Skin Patch Sales Volume by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 23. Global Skin Patch Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Skin Patch Sales Volume Share by Application (2021-2032) Figure 25. Global Skin Patch Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Skin Patch Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Skin Patch Sales Value Share by Application (2021-2032) Figure 28. Global Skin Patch Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 29. Global Skin Patch Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Skin Patch Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Skin Patch Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 33. North America Skin Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Skin Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Skin Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 39. South America Skin Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Skin Patch Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Skin Patch Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Skin Patch Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Skin Patch Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Skin Patch Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Skin Patch Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Skin Patch Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Buprenorphine
  • Fentanyl
  • Clonidine
  • Nicotine
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • GSK
  • Teva Pharmaceutical Industries
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Mylan
  • Lingrui
  • Bayer
  • Teikoku Seiyaku
  • Purdue Pharma
  • Mundipharma International
  • Luye Pharma Group
  • Hisamitsu Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Skin Patch Sales Value (2021-2032)
  4. 1.2.2 Global Skin Patch Sales Volume (2021-2032)
  5. 1.2.3 Global Skin Patch Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Skin Patch Market Dynamics
  1. 2.1 Skin Patch Industry Trends
  2. 2.2 Skin Patch Industry Drivers
  3. 2.3 Skin Patch Industry Opportunities and Challenges
  4. 2.4 Skin Patch Industry Restraints
3 Skin Patch Market by Company
  1. 3.1 Global Skin Patch Company Revenue Ranking in 2025
  2. 3.2 Global Skin Patch Revenue by Company (2021-2026)
  3. 3.3 Global Skin Patch Sales Volume by Company (2021-2026)
  4. 3.4 Global Skin Patch Average Price by Company (2021-2026)
  5. 3.5 Global Skin Patch Company Ranking (2024-2026)
  6. 3.6 Global Skin Patch Company Manufacturing Base and Headquarters
  7. 3.7 Global Skin Patch Company Product Type and Application
  8. 3.8 Global Skin Patch Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Skin Patch Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Skin Patch Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Skin Patch Market by Type
  1. 4.1 Skin Patch Type Introduction
  2. 4.1.1 Buprenorphine
  3. 4.1.2 Fentanyl
  4. 4.1.3 Clonidine
  5. 4.1.4 Nicotine
  6. 4.2 Global Skin Patch Sales Volume by Type
  7. 4.2.1 Global Skin Patch Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Skin Patch Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Skin Patch Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Skin Patch Sales Value by Type
  11. 4.3.1 Global Skin Patch Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Skin Patch Sales Value by Type (2021-2032)
  13. 4.3.3 Global Skin Patch Sales Value Share by Type (2021-2032)
5 Skin Patch Market by Application
  1. 5.1 Skin Patch Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Skin Patch Sales Volume by Application
  6. 5.2.1 Global Skin Patch Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Skin Patch Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Skin Patch Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Skin Patch Sales Value by Application
  10. 5.3.1 Global Skin Patch Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Skin Patch Sales Value by Application (2021-2032)
  12. 5.3.3 Global Skin Patch Sales Value Share by Application (2021-2032)
6 Skin Patch Regional Sales and Value Analysis
  1. 6.1 Global Skin Patch Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Skin Patch Sales by Region (2021-2032)
  3. 6.2.1 Global Skin Patch Sales by Region: 2021-2026
  4. 6.2.2 Global Skin Patch Sales by Region (2027-2032)
  5. 6.3 Global Skin Patch Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Skin Patch Sales Value by Region (2021-2032)
  7. 6.4.1 Global Skin Patch Sales Value by Region: 2021-2026
  8. 6.4.2 Global Skin Patch Sales Value by Region (2027-2032)
  9. 6.5 Global Skin Patch Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Skin Patch Sales Value (2021-2032)
  12. 6.6.2 North America Skin Patch Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Skin Patch Sales Value (2021-2032)
  15. 6.7.2 Europe Skin Patch Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Skin Patch Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Skin Patch Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Skin Patch Sales Value (2021-2032)
  21. 6.9.2 South America Skin Patch Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Skin Patch Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Skin Patch Sales Value Share by Country, 2025 VS 2032
7 Skin Patch Country-level Sales and Value Analysis
  1. 7.1 Global Skin Patch Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Skin Patch Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Skin Patch Sales by Country (2021-2032)
  4. 7.3.1 Global Skin Patch Sales by Country (2021-2026)
  5. 7.3.2 Global Skin Patch Sales by Country (2027-2032)
  6. 7.4 Global Skin Patch Sales Value by Country (2021-2032)
  7. 7.4.1 Global Skin Patch Sales Value by Country (2021-2026)
  8. 7.4.2 Global Skin Patch Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Skin Patch Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Skin Patch Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Skin Patch Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Skin Patch Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Skin Patch Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Skin Patch Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Skin Patch Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Skin Patch Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Skin Patch Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Skin Patch Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Skin Patch Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Skin Patch Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Skin Patch Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Skin Patch Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Skin Patch Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Skin Patch Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Skin Patch Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Skin Patch Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Skin Patch Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Skin Patch Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Skin Patch Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Skin Patch Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Skin Patch Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Skin Patch Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Skin Patch Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Skin Patch Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Skin Patch Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Skin Patch Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Skin Patch Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Skin Patch Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Skin Patch Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Skin Patch Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Skin Patch Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Skin Patch Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Skin Patch Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Skin Patch Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Skin Patch Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Skin Patch Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Skin Patch Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Skin Patch Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Skin Patch Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Skin Patch Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Skin Patch Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Skin Patch Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Skin Patch Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Skin Patch Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Skin Patch Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Skin Patch Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Skin Patch Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Skin Patch Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Skin Patch Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Skin Patch Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Skin Patch Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Skin Patch Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Skin Patch Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Skin Patch Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Skin Patch Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Skin Patch Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Skin Patch Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Skin Patch Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Skin Patch Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Skin Patch Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Skin Patch Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Skin Patch Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Skin Patch Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Skin Patch Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Skin Patch Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Skin Patch Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Skin Patch Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Skin Patch Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Skin Patch Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Skin Patch Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Skin Patch Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Skin Patch Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Skin Patch Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Skin Patch Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Skin Patch Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Skin Patch Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Skin Patch Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Skin Patch Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Skin Patch Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Skin Patch Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Skin Patch Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Skin Patch Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Skin Patch Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 GSK Skin Patch Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Teva Pharmaceutical Industries
  8. 8.2.1 Teva Pharmaceutical Industries Company Information
  9. 8.2.2 Teva Pharmaceutical Industries Business Overview
  10. 8.2.3 Teva Pharmaceutical Industries Skin Patch Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceutical Industries Skin Patch Product Portfolio
  12. 8.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Skin Patch Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Skin Patch Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Skin Patch Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Skin Patch Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Skin Patch Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Skin Patch Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Skin Patch Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Skin Patch Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Lingrui
  38. 8.7.1 Lingrui Company Information
  39. 8.7.2 Lingrui Business Overview
  40. 8.7.3 Lingrui Skin Patch Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lingrui Skin Patch Product Portfolio
  42. 8.7.5 Lingrui Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Skin Patch Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Skin Patch Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Teikoku Seiyaku
  50. 8.9.1 Teikoku Seiyaku Company Information
  51. 8.9.2 Teikoku Seiyaku Business Overview
  52. 8.9.3 Teikoku Seiyaku Skin Patch Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Teikoku Seiyaku Skin Patch Product Portfolio
  54. 8.9.5 Teikoku Seiyaku Recent Developments
  55. 8.10 Purdue Pharma
  56. 8.10.1 Purdue Pharma Company Information
  57. 8.10.2 Purdue Pharma Business Overview
  58. 8.10.3 Purdue Pharma Skin Patch Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Purdue Pharma Skin Patch Product Portfolio
  60. 8.10.5 Purdue Pharma Recent Developments
  61. 8.11 Mundipharma International
  62. 8.11.1 Mundipharma International Company Information
  63. 8.11.2 Mundipharma International Business Overview
  64. 8.11.3 Mundipharma International Skin Patch Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Mundipharma International Skin Patch Product Portfolio
  66. 8.11.5 Mundipharma International Recent Developments
  67. 8.12 Luye Pharma Group
  68. 8.12.1 Luye Pharma Group Company Information
  69. 8.12.2 Luye Pharma Group Business Overview
  70. 8.12.3 Luye Pharma Group Skin Patch Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Luye Pharma Group Skin Patch Product Portfolio
  72. 8.12.5 Luye Pharma Group Recent Developments
  73. 8.13 Hisamitsu Pharmaceutical
  74. 8.13.1 Hisamitsu Pharmaceutical Company Information
  75. 8.13.2 Hisamitsu Pharmaceutical Business Overview
  76. 8.13.3 Hisamitsu Pharmaceutical Skin Patch Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Hisamitsu Pharmaceutical Skin Patch Product Portfolio
  78. 8.13.5 Hisamitsu Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Skin Patch Value Chain Analysis
  2. 9.1.1 Skin Patch Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Skin Patch Sales Mode & Process
  6. 9.2 Skin Patch Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Skin Patch Distributors
  9. 9.2.3 Skin Patch Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst